Unknown

Dataset Information

0

Regulation of ?-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase.


ABSTRACT: Rab5 GTPase modulates the trafficking of the cell surface receptors, including G protein-coupled ?-adrenergic receptors (?-ARs). Here, we have determined the role of Rab5 in regulating the internalization of ?-ARs in lung microvascular endothelial cells (LMECs) and in maintaining the integrity and permeability of endothelial cell barrier. Our data demonstrate that lipopolysaccharide (LPS) treatment disrupts LMEC barrier function and reduces the cell surface expression of ?-ARs. Furthermore, the activation of ?-ARs, particularly ?2-AR, is able to protect the LMEC permeability from LPS injury. Moreover, siRNA-mediated knockdown of Rab5 inhibits both the basal and agonist-provoked internalization of ?-ARs, therefore, enhancing the cell surface expression of the receptors and receptor-mediated ERK1/2 activation. Importantly, knockdown of Rab5 not only inhibits the LPS-induced effects on ?-ARs but also protects the LMEC monolayer permeability. All together, these data provide strong evidence indicating a crucial role of Rab5-mediated internalization of ?-ARs in functional regulation of LMECs.

SUBMITTER: Yang J 

PROVIDER: S-EPMC4495405 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of β-adrenergic receptor trafficking and lung microvascular endothelial cell permeability by Rab5 GTPase.

Yang Junjun J   Sun Huan H   Zhang Jihang J   Hu Mingdong M   Wang Jianchun J   Wu Guangyu G   Wang Guansong G  

International journal of biological sciences 20150601 8


Rab5 GTPase modulates the trafficking of the cell surface receptors, including G protein-coupled β-adrenergic receptors (β-ARs). Here, we have determined the role of Rab5 in regulating the internalization of β-ARs in lung microvascular endothelial cells (LMECs) and in maintaining the integrity and permeability of endothelial cell barrier. Our data demonstrate that lipopolysaccharide (LPS) treatment disrupts LMEC barrier function and reduces the cell surface expression of β-ARs. Furthermore, the  ...[more]

Similar Datasets

| S-EPMC4406342 | biostudies-literature
| S-EPMC2630185 | biostudies-literature
| S-EPMC3894203 | biostudies-literature
| S-EPMC6090509 | biostudies-literature
| S-EPMC4827161 | biostudies-literature
| S-EPMC7528930 | biostudies-literature
| S-EPMC7896340 | biostudies-literature
| S-EPMC6355231 | biostudies-literature
| S-EPMC2695703 | biostudies-literature
| S-EPMC4542279 | biostudies-literature